X Fab Silicon Foundries EV (XFAB)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 5.385 |
|---|---|
| 52-week range | 4.094 – 15.880 |
| Return, 1 month / 3 months | −11.7% / −28.1% |
| Return, 1 year / 3 years | −17.5% / −36.9% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 72.0% |
| Worst drawdown (1 year) | -55.9% |
| Average daily value traded | 2.25M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
X-FAB Silicon Foundries is a semiconductor foundry group based in Erfurt, Germany. It manufactures analog and mixed-signal integrated circuits for other companies, using specialty process technologies such as CMOS and BCD. Its customers are chip designers and electronics manufacturers serving automotive, industrial, medical and consumer markets, and it operates fabrication plants in several countries. The company provides foundry services rather than selling its own branded chips, working with customers from design support through volume production.
X Fab Silicon Foundries EV trades under the code XFAB on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
X Fab Silicon Foundries EV (XFAB) trades on the Euronext Paris in France. It last closed at EUR 5.385 on 19 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 453 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.5% and over the last three months it fell 28.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.0% | ||
| From 52-week high | -55.9% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -28.1% | ||
| 6-month return | -19.0% | ||
| 12-month return, skipping the last month | -6.5% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 72.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.9% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 2.25M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −9.6% |
|---|---|
| 1 month | −11.7% |
| 3 months | −28.1% |
| 6 months | −19.0% |
| 1 year | −17.5% |
| 3 years | −36.9% |
| 5 years | −42.7% |
Signals
| 50-day / 200-day average | 6.262 / 6.489 |
|---|---|
| Golden / death cross (60 days) | Death, 13 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.307 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.